ATO potentially reduces infiltration of macrophages into the TME and impairs IL-1β secretion from macrophages, indicating a potential role for ATO in overcoming the chemotherapeutic resistance generated by the interaction between TAMs and HNSCC. Here, IL1B is linked to head and neck squamous cell carcinoma.